^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Lung Adenocarcinoma |
| Drug: | albumin-bound paclitaxel (Bcl2 inhibitor, Tubulin inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
SYSTEMIC THERAPY FOR ADVANCED OR METASTATIC DISEASE – PROGRESSION...ADENOCARCINOMA, LARGE CELL, NSCLC NOS...albumin bound paclitaxel (category 2B).
